Design and rationale for the life after stopping tyrosine kinase inhibitors (LAST) study, a prospective, single-group longitudinal study in patients with chronic myeloid leukemia Academic Article uri icon

Overview

MeSH Major

  • Myelodysplastic Syndromes

abstract

  • This study was registered prospectively on October 21, 2014 and assigned trial number NCT02269267 .

publication date

  • April 2, 2018

Research

keywords

  • Academic Article

Identity

Language

  • eng

PubMed Central ID

  • PMC5879565

Digital Object Identifier (DOI)

  • 10.1186/s12885-018-4273-1

PubMed ID

  • 29609532

Additional Document Info

start page

  • 359

volume

  • 18

number

  • 1